Search
Coauthors
Michael Hebeisen Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Switzerland
1 protocol

Nathalie Rufer Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Switzerland
1 protocol

Daniel Speiser Ludwig Center for Cancer Research (LICR), Lausanne Branch, Switzerland
1 protocol

Petra Baumgaertner Ludwig Center for Cancer Research (LICR), Lausanne Branch, Switzerland
1 protocol

Pedro Romero
  • Ludwig Center for Cancer Research (LICR), Lausanne Branch, Switzerland
  • 3 Author merit

Education

MD in School of Medicine of the National University of Colombia

Current position

Postdoctoral fellow in immunology of malaria and malaria vaccines, at the Institute of Immunology, Faculty of Medicine, National University of Colombia and New York University School of Medicine
Member of the Ludwig Center for Cancer Research and full Professor at the Faculty of Biology and Medicine of the University of Lausanne
Leader of the Translational Tumor Immunology Group at the Ludwig Center
Associate Director of the Division of Fundamental Oncology at the Lausanne University Hospital
Editor-in-chief of the Journal for Immunotherapy of Cancer
Section Editor at the Journal of Immunology






3 Protocols published
Chromium-51 (51Cr) Release Assay to Assess Human T Cells for Functional Avidity and Tumor Cell Recognition
Authors:  Petra Baumgaertner, Daniel E. Speiser, Pedro Romero, Nathalie Rufer and Michael Hebeisen, date: 08/20/2016, view: 2877, Q&A: 0
Cytotoxic CD8+ T cells are able to specifically recognize and kill target cells through specific interaction between their T cell receptors (TCRs) and small immunogenic peptides (antigens) presented by major histocompatibility complex ...
Analysis of Tumor-infiltrating Lymphocytes Following CD45 Enrichment
Measuring antigen-specific T cell responses in the blood and lymphoid organs of vaccinated mice can give us a useful indication of the potency of a vaccine formulation. Unfortunately, systemic or even localized lymphoid T cell responses are not ...